Qipengyuania citrea

参考价:¥1
供货周期: --
品牌: 百欧博伟生物
规格: 培养物/冻干粉
货号: bio-115874
CAS号: DSM 14432
北京百欧博伟生物技术有限公司
银牌会员4年生产商
关注展位 全部试剂
产品详情

Qipengyuania citrea

DSM 14432

BACTERIA

 How to read the following data (Example)

Name:

Qipengyuania citrea (Denner et al. 2002) Xu et al. 2020

DSM No.:

14432, Type strain

Strain designation:

RE35F/1

Other collection no.

or WDCM no.:

CIP 107092

Isolated from:

seawater

Country:

France

Corsica, Bay of Calvi

Date of sampling:

before 27.07.2001

Nagoya Protocol Restrictions:

France requires a benefit-sharing declaration for French genetic resources at the time of utilization, i.e., conducting research. France considers access to genetic resources when utilization begins and not when the initial collection of the material took place and applies to material both in-situ and ex-situ and users within and outside of France.

 

To comply with French law, you, the user need to make a Declaration regarding access to genetic resources and benefit-sharing arising from your non-commercial utilisation of genetic resources. The steps are the following:

 

   1. File a declaration via the CERFA form n. 15786 (https://www.formulaires.service-public.fr/gf/getAnnexe.do?cerfaAnnexe=1&cerfaFormulaire=15786*02) or by electronic procedure (https://www.demarches-simplifiees.fr/commencer/apa-declaration-pmorale)

   2. Await approval by the Ministry for the Ecological Transition, the competent national authority

   3. Respond to any requests for more information from the competent national authority

   4. Receive an acknowledgment of receipt by the competent national authority certifying the prior informed consent (PIC) and establishment of mutually agreed terms (MAT) regarding benefit-sharing. This procedure shall not exceed 2 months.

 

For more information about this topic please see the Access and Benefit-Sharing Clearing House: https://absch.cbd.int/en/countries/FR

For more information about the commercial use of this genetic resources please contact: justiziariat@dsmz.de

 

 

History:

<- E. B. M. Denner; RE35F/1 <- D. Vybiral

Genbank accession numbers:

16S rRNA gene: AF118020

Cultivation conditions:

Medium 514 , 20°C

 

Complete DSMZ Media List

Summary and

additional information:

<- E. B. M. Denner; RE35F/1 <- D. Vybiral. Seawater; France. Type strain. Taxonomy/description (8585, 8697). Sequence accession no. 16S rRNA gene: AF118020. (Medium 514, 20°C).

Literature:

8585, 8697

Risk group:

1 (classification according to German TRBA)

Supplied as:

Delivery form Prices


Qipengyuania citrea 信息由北京百欧博伟生物技术有限公司为您提供,如您想了解更多关于 Qipengyuania citrea 报价、型号、参数等信息, 欢迎来电或留言咨询。除供应 Qipengyuania citrea 外,北京百欧博伟生物技术有限公司还可为您提供其他等产品, 公司有专业的客户服务团队,是您值得信赖的合作伙伴。

相关产品

当前位置: 仪器信息网 百欧博伟生物 试剂 Qipengyuania citrea

关注

拨打电话

留言咨询